Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rγnull mice engrafted with human peripheral blood mononuclear cells

Clinical and Experimental Immunology

Volumn 172, Issue 2, 2013, Pages 349-362

  Nolte, T ^a   Zadeh Khorasani, M ^b   Safarov, O ^b   Rueff, F ^b   Gulberg V ^b   Herbach, N ^a   Wollenberg, A ^b   Mueller, T ^c   Siebeck, M ^b   Wolf, E ^a   Gropp, R ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Animal models studies mice rats; CD1 restricted natural killer T cells (NKT cells); CD4 T cells (T helper; Inflammatory bowel disease; Th0; Th1; Th17); Th2; Th3

Indexed keywords

ALCOHOL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR GAMMA; OXAZOLONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLITIS; CROSS REACTION; CYTOKINE RELEASE; EDEMA; ENGRAFTMENT; FIBROSIS; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; LAMINA PROPRIA; LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN; T LYMPHOCYTE;

ANIMALS; CELL LINE; COLITIS, ULCERATIVE; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ETHANOL; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; OXAZOLONE; RECEPTORS, INTERLEUKIN-2; TRANSPLANTATION, HETEROLOGOUS;

EID: 84876090361     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12057     Document Type: Article

References (28)

1. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-521.
2. Niebuhr M, Werfel T. Innate immunity, allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2010; 10:463-468.
3. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188:1929-1939.
4. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002; 17:629-638.
5. Obara W, Kawa Y, Ra C, Nishioka K, Soma Y, Mizoguchi M. T cells and mast cells as a major source of interleukin-13 in atopic dermatitis. Dermatology 2002; 205:11-17.
6. Heller F, Florian P, Bojarski C etal. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005; 129:550-564.
7. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003; 111:291-297.
8. Mueller TD, Zhang JL, Sebald W, Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta 2002; 1592:237-250.
9. Man MQ, Hatano Y, Lee SH etal. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 2008; 128:79-86.
10. Kojima R, Kuroda S, Ohkishi T, Nakamaru K, Hatakeyama S. Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis. J Pharmacol Sci 2004; 96:307-313.
11. Kobayashi S, Haruo N, Sugane K, Ochs HD, Agematsu K. Interleukin-21 stimulates B-cell immunoglobulin E synthesis in human beings concomitantly with activation-induced cytidine deaminase expression and differentiation into plasma cells. Hum Immunol 2009; 70:35-40.
12. Mayer RJ, Bolognese BJ, Al-Mahdi N etal. Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice. Clin Exp Allergy 2000; 30:719-727.
13. Khalil PN, Weiler V, Nelson PJ etal. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 2007; 132:944-954.
14. Daniel C, Sartory NA, Zahn N etal. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Mol Immunol 2007; 44:3305-3316.
15. Van der Heijden PJ, Stok W. Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. J Immunol Methods 1987; 103:161-167.
16. Nolte T, Zadeh-Khorasani M, Safarov O etal. Induction of oxazolone mediated features of atopic dermatitis in NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells. Dis Model Mech 2013; 6:125-134.
17. null mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways. J Transl Med 2013; 11:4-10.
18. King M, Pearson T, Shultz LD etal. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol 2008; 126:303-314.
19. Takayama G, Arima K, Kanaji T etal. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006; 118:98-104.
20. Masuoka M, Shiraishi H, Ohta S etal. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 2012; 122:2590-2600.
21. Sidhu SS, Yuan S, Innes AL etal. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA 2010; 107:14170-14175.
22. Shultz LD, Pearson T, King M etal. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research. Ann NY Acad Sci 2007; 1103:77-89.
23. Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994; 84:3540-3549.
24. Pan L, Delmonte J, Jr, Jalonen CK, Ferrara JL. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86:4422-4429.
25. Krenger W, Snyder KM, Byon JC, Falzarano G, Ferrara JL. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 1995; 155:585-593.
26. Jowett SL, Seal CJ, Pearce MS etal. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53:1479-1484.
27. Koeper LM, Schulz A, Ahr HJ, Vohr HW. In vitro differentiation of skin sensitizers by cell signaling pathways. Toxicology 2007; 242:144-152.
28. Franke A, Balschun T, Sina C etal. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet 2010; 42:292-294.